New Strategy Could Yield More Precise Seasonal Flu Vaccine

Researcher's new method is the first demonstration that one can accurately anticipate future seasonal influenza strains in the lab

Brought to you byUniversity of Wisconsin-Madison
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.

While this year’s vaccine is a much better match to the circulating seasonal strains of influenza, the shifty nature of the virus and the need to pick the viruses used to make global vaccine stocks well before the onset of the flu season can make vaccine strain selection a shot in the dark.

Related Article: Scientists Find Minor Flu Strains Pack Bigger Punch

That process—dependent on the careful selection of circulating virus strains and the identification of mutations in the part of the virus that recognizes host cells—could soon be augmented by a new approach. It would more precisely forecast the naturally occurring mutations that help seasonal flu virus dodge the vaccine.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.
Add Lab Manager as a preferred source on Google

Add Lab Manager as a preferred Google source to see more of our trusted coverage.

Related Topics

Current Magazine Issue Background Image

CURRENT ISSUE - October 2026

Why Lab Teams Resist Change—And How Leaders Can Respond

Addressing the human side of automation, AI, and operational change

October 2026 Lab Manager Cover Image